Comparative Clinical Evaluation of Daily Disposable Lenses in Symptomatic Frequent Replacement (FRP) Lens Wearers
The trial intends to compare the extent to which symptoms improve in symptomatic daily wear contact lens wearers who replace their lenses at intervals of 2 weeks or monthly when fit with DAILIES AquaComfort Plus versus 1-Day Acuvue TruEye, 1-Day Acuvue Moist, Proclear 1 Day, and SofLens daily disposable worn on a daily wear, daily disposable basis.
Allocation: Randomized, Control: Active Control, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Supportive Care
nelfilcon A with additional UHMW PVA, narafilcon A, etafilcon A, omafilcon A, hilafilcon B
David Wakabayashi, OD
Results (where available)
- Source: http://clinicaltrials.gov/show/NCT00953407
- Information obtained from ClinicalTrials.gov on July 15, 2010
The purpose of this study is to evaluate the performance of the nelfilcon A lens compared to a competitive daily disposable lens, narafilcon A, in a population of neophytes (new wearers).
The primary objective of this trial is to validate the improvements made to the OK inversion indicator. Visibility on eye and on finger will be assessed by the subjects
The objective of this study is to evaluate the clinical performance of two daily disposable contact lenses.
This study seeks to evaluate the clinical fitting performance of a new daily disposable contact lens to an existing daily disposable contact lens.
This study seeks to evaluate the clinical performance of a new CE marked daily disposable contact lens that contains a wetting agent to a recently improved daily disposable contact lens.
Determination of free volume holes of the hydrogel and silicone-hydrogel polymer contact lenses were investigated. Two types of polymer contact lenses were used as materials: the first is a hydrogel c...
In this study we evaluated US as an additional classification item in the ACR classification of SS.
Abstract Purpose: To develop a contact lens system that will control the release of an osmoprotectant and a moisturizing agent with the aim to reduce symptoms of ocular dryness. Materials and methods:...
According to the German Pharmaceutical Market Reorganisation Act [Arzneimittelmarktneuordnungsgesetz (AMNOG)] of 22.12.2010, the benefit assessment of a new drug should include an evaluation of the "d...
The purpose of this study was to determine the prevalence and etiology of hearing impairment (HI) in Finnish children and to evaluate the frequency and type of additional disabilities among children w...
Medical and Biotech [MESH] Definitions
A secreted endopeptidase homologous with INTERSTITIAL COLLAGENASE, but which possesses an additional fibronectin-like domain.
Steroids with a hydroxyl group at C-3 and most of the skeleton of cholestane. Additional carbon atoms may be present in the side chain. (IUPAC Steroid Nomenclature, 1987)
A stochastic process such that the conditional probability distribution for a state at any future instant, given the present state, is unaffected by any additional knowledge of the past history of the system.
A layer of living cells between the bark and hardwood that each year produces additional wood and bark cells, forming concentric growth rings.
A biosynthetic precursor of collagen containing additional amino acid sequences at the amino-terminal and carboxyl-terminal ends of the polypeptide chains.